nodes	percent_of_prediction	percent_of_DWPC	metapath
Spironolactone—SHBG—osteoporosis	0.294	1	CbGaD
Spironolactone—Methyltestosterone—Ethinyl Estradiol—osteoporosis	0.0902	0.523	CrCrCtD
Spironolactone—SHBG—Estropipate—osteoporosis	0.0895	0.222	CbGbCtD
Spironolactone—Testosterone—Estradiol—osteoporosis	0.0823	0.477	CrCrCtD
Spironolactone—AR—Ergocalciferol—osteoporosis	0.0599	0.148	CbGbCtD
Spironolactone—SHBG—Ethinyl Estradiol—osteoporosis	0.0577	0.143	CbGbCtD
Spironolactone—SHBG—Estradiol—osteoporosis	0.0372	0.0921	CbGbCtD
Spironolactone—AR—Estradiol—osteoporosis	0.0311	0.0771	CbGbCtD
Spironolactone—ABCC2—Ethinyl Estradiol—osteoporosis	0.0219	0.0543	CbGbCtD
Spironolactone—SLCO1A2—Conjugated Estrogens—osteoporosis	0.0194	0.0481	CbGbCtD
Spironolactone—SLCO1A2—Estradiol—osteoporosis	0.017	0.0422	CbGbCtD
Spironolactone—ABCC2—Conjugated Estrogens—osteoporosis	0.0161	0.0399	CbGbCtD
Spironolactone—CYP2C8—Raloxifene—osteoporosis	0.0109	0.0271	CbGbCtD
Spironolactone—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0106	0.0262	CbGbCtD
Spironolactone—CYP2C8—Cholecalciferol—osteoporosis	0.00844	0.0209	CbGbCtD
Spironolactone—ABCB1—Ethinyl Estradiol—osteoporosis	0.00715	0.0177	CbGbCtD
Spironolactone—CYP2C8—Estradiol—osteoporosis	0.00681	0.0169	CbGbCtD
Spironolactone—ABCB1—Conjugated Estrogens—osteoporosis	0.00525	0.013	CbGbCtD
Spironolactone—ABCB1—Estradiol—osteoporosis	0.00461	0.0114	CbGbCtD
Spironolactone—Testolactone—CYP19A1—osteoporosis	0.000439	0.177	CrCbGaD
Spironolactone—Cramp muscle—Ibandronate—osteoporosis	0.000435	0.00554	CcSEcCtD
Spironolactone—Gastritis—Ibandronate—osteoporosis	0.000428	0.00544	CcSEcCtD
Spironolactone—Cramps of lower extremities—Conjugated Estrogens—osteoporosis	0.000422	0.00536	CcSEcCtD
Spironolactone—Breast pain—Estradiol—osteoporosis	0.000421	0.00535	CcSEcCtD
Spironolactone—Agranulocytosis—Etidronic acid—osteoporosis	0.000419	0.00533	CcSEcCtD
Spironolactone—Amenorrhoea—Estradiol—osteoporosis	0.000418	0.00532	CcSEcCtD
Spironolactone—Renal failure acute—Pamidronate—osteoporosis	0.00041	0.00522	CcSEcCtD
Spironolactone—Ulcer—Estradiol—osteoporosis	0.000388	0.00494	CcSEcCtD
Spironolactone—Lethargy—Pamidronate—osteoporosis	0.000386	0.00492	CcSEcCtD
Spironolactone—Erythema multiforme—Etidronic acid—osteoporosis	0.000381	0.00485	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Alendronate—osteoporosis	0.000379	0.00482	CcSEcCtD
Spironolactone—Renal failure acute—Zoledronate—osteoporosis	0.000375	0.00477	CcSEcCtD
Spironolactone—Renal failure—Ibandronate—osteoporosis	0.000366	0.00466	CcSEcCtD
Spironolactone—Drowsiness—Calcitriol—osteoporosis	0.000365	0.00464	CcSEcCtD
Spironolactone—Renal failure acute—Conjugated Estrogens—osteoporosis	0.000361	0.00459	CcSEcCtD
Spironolactone—Feeling abnormal—Calcium Acetate—osteoporosis	0.000359	0.00457	CcSEcCtD
Spironolactone—Alopecia—Etidronic acid—osteoporosis	0.000356	0.00453	CcSEcCtD
Spironolactone—Lethargy—Zoledronate—osteoporosis	0.000353	0.00449	CcSEcCtD
Spironolactone—Gastritis—Risedronate—osteoporosis	0.000353	0.00448	CcSEcCtD
Spironolactone—Cramp muscle—Pamidronate—osteoporosis	0.000341	0.00434	CcSEcCtD
Spironolactone—Muscle spasms—Etidronic acid—osteoporosis	0.000337	0.00429	CcSEcCtD
Spironolactone—Cramps of lower extremities—Estradiol—osteoporosis	0.000337	0.00429	CcSEcCtD
Spironolactone—Gastritis—Pamidronate—osteoporosis	0.000335	0.00426	CcSEcCtD
Spironolactone—Erythema multiforme—Estropipate—osteoporosis	0.00033	0.00419	CcSEcCtD
Spironolactone—Gynaecomastia—Estradiol—osteoporosis	0.000329	0.00418	CcSEcCtD
Spironolactone—Erythema multiforme—Alendronate—osteoporosis	0.000325	0.00413	CcSEcCtD
Spironolactone—Hypersensitivity—Calcium Acetate—osteoporosis	0.000321	0.00409	CcSEcCtD
Spironolactone—Leukopenia—Etidronic acid—osteoporosis	0.000314	0.00399	CcSEcCtD
Spironolactone—Cramp muscle—Zoledronate—osteoporosis	0.000311	0.00396	CcSEcCtD
Spironolactone—Erythema multiforme—Calcitriol—osteoporosis	0.00031	0.00394	CcSEcCtD
Spironolactone—Pruritus—Calcium Acetate—osteoporosis	0.000309	0.00393	CcSEcCtD
Spironolactone—Alopecia—Estropipate—osteoporosis	0.000308	0.00392	CcSEcCtD
Spironolactone—Gastritis—Zoledronate—osteoporosis	0.000306	0.00389	CcSEcCtD
Spironolactone—Alopecia—Alendronate—osteoporosis	0.000304	0.00386	CcSEcCtD
Spironolactone—Fluoxymesterone—SHBG—osteoporosis	0.000301	0.122	CrCbGaD
Spironolactone—Cramp muscle—Conjugated Estrogens—osteoporosis	0.0003	0.00381	CcSEcCtD
Spironolactone—Diarrhoea—Calcium Acetate—osteoporosis	0.000298	0.0038	CcSEcCtD
Spironolactone—Alopecia—Ibandronate—osteoporosis	0.000296	0.00376	CcSEcCtD
Spironolactone—Discomfort—Etidronic acid—osteoporosis	0.000295	0.00375	CcSEcCtD
Spironolactone—Muscle spasms—Estropipate—osteoporosis	0.000292	0.00371	CcSEcCtD
Spironolactone—Confusional state—Etidronic acid—osteoporosis	0.000289	0.00367	CcSEcCtD
Spironolactone—Dizziness—Calcium Acetate—osteoporosis	0.000288	0.00367	CcSEcCtD
Spironolactone—Muscle spasms—Alendronate—osteoporosis	0.000287	0.00366	CcSEcCtD
Spironolactone—Renal failure—Pamidronate—osteoporosis	0.000287	0.00365	CcSEcCtD
Spironolactone—Muscle spasms—Raloxifene—osteoporosis	0.000283	0.0036	CcSEcCtD
Spironolactone—Muscle spasms—Ibandronate—osteoporosis	0.00028	0.00356	CcSEcCtD
Spironolactone—Ill-defined disorder—Alendronate—osteoporosis	0.000277	0.00353	CcSEcCtD
Spironolactone—Vomiting—Calcium Acetate—osteoporosis	0.000277	0.00353	CcSEcCtD
Spironolactone—Agranulocytosis—Pamidronate—osteoporosis	0.000272	0.00346	CcSEcCtD
Spironolactone—Lethargy—Estradiol—osteoporosis	0.000272	0.00346	CcSEcCtD
Spironolactone—Ill-defined disorder—Ibandronate—osteoporosis	0.00027	0.00344	CcSEcCtD
Spironolactone—Malaise—Alendronate—osteoporosis	0.00027	0.00343	CcSEcCtD
Spironolactone—Erythema multiforme—Ethinyl Estradiol—osteoporosis	0.000267	0.0034	CcSEcCtD
Spironolactone—Malaise—Ibandronate—osteoporosis	0.000263	0.00334	CcSEcCtD
Spironolactone—Renal failure—Zoledronate—osteoporosis	0.000262	0.00333	CcSEcCtD
Spironolactone—Nausea—Calcium Acetate—osteoporosis	0.000259	0.0033	CcSEcCtD
Spironolactone—Medroxyprogesterone Acetate—SHBG—osteoporosis	0.000258	0.104	CrCbGaD
Spironolactone—Renal failure—Conjugated Estrogens—osteoporosis	0.000252	0.00321	CcSEcCtD
Spironolactone—Discomfort—Alendronate—osteoporosis	0.000252	0.0032	CcSEcCtD
Spironolactone—Alopecia—Ethinyl Estradiol—osteoporosis	0.00025	0.00318	CcSEcCtD
Spironolactone—Agranulocytosis—Zoledronate—osteoporosis	0.000249	0.00316	CcSEcCtD
Spironolactone—Anaphylactic shock—Estropipate—osteoporosis	0.000248	0.00315	CcSEcCtD
Spironolactone—Discomfort—Ibandronate—osteoporosis	0.000245	0.00311	CcSEcCtD
Spironolactone—Methyltestosterone—SHBG—osteoporosis	0.000243	0.0982	CrCbGaD
Spironolactone—Cramp muscle—Estradiol—osteoporosis	0.00024	0.00305	CcSEcCtD
Spironolactone—Discomfort—Calcitriol—osteoporosis	0.00024	0.00305	CcSEcCtD
Spironolactone—Anaphylactic shock—Ibandronate—osteoporosis	0.000238	0.00302	CcSEcCtD
Spironolactone—Muscle spasms—Ethinyl Estradiol—osteoporosis	0.000237	0.00301	CcSEcCtD
Spironolactone—Feeling abnormal—Etidronic acid—osteoporosis	0.000236	0.003	CcSEcCtD
Spironolactone—Gastritis—Estradiol—osteoporosis	0.000236	0.003	CcSEcCtD
Spironolactone—Thrombocytopenia—Raloxifene—osteoporosis	0.000235	0.00299	CcSEcCtD
Spironolactone—Anaphylactic shock—Calcitriol—osteoporosis	0.000233	0.00296	CcSEcCtD
Spironolactone—Alopecia—Pamidronate—osteoporosis	0.000232	0.00294	CcSEcCtD
Spironolactone—Muscle spasms—Risedronate—osteoporosis	0.000231	0.00293	CcSEcCtD
Spironolactone—Nausea—Ergocalciferol—osteoporosis	0.000229	0.00291	CcSEcCtD
Spironolactone—Ill-defined disorder—Ethinyl Estradiol—osteoporosis	0.000228	0.0029	CcSEcCtD
Spironolactone—Urticaria—Etidronic acid—osteoporosis	0.000228	0.00289	CcSEcCtD
Spironolactone—Malaise—Ethinyl Estradiol—osteoporosis	0.000222	0.00282	CcSEcCtD
Spironolactone—Somnolence—Estropipate—osteoporosis	0.00022	0.0028	CcSEcCtD
Spironolactone—Muscle spasms—Pamidronate—osteoporosis	0.000219	0.00279	CcSEcCtD
Spironolactone—Erythema multiforme—Conjugated Estrogens—osteoporosis	0.000218	0.00277	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Estropipate—osteoporosis	0.000214	0.00272	CcSEcCtD
Spironolactone—Ill-defined disorder—Pamidronate—osteoporosis	0.000212	0.00269	CcSEcCtD
Spironolactone—Alopecia—Zoledronate—osteoporosis	0.000211	0.00269	CcSEcCtD
Spironolactone—Hypersensitivity—Etidronic acid—osteoporosis	0.000211	0.00268	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000207	0.00264	CcSEcCtD
Spironolactone—Discomfort—Ethinyl Estradiol—osteoporosis	0.000207	0.00263	CcSEcCtD
Spironolactone—Somnolence—Calcitriol—osteoporosis	0.000207	0.00263	CcSEcCtD
Spironolactone—Malaise—Pamidronate—osteoporosis	0.000206	0.00262	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000205	0.00261	CcSEcCtD
Spironolactone—Leukopenia—Pamidronate—osteoporosis	0.000204	0.0026	CcSEcCtD
Spironolactone—Alopecia—Conjugated Estrogens—osteoporosis	0.000204	0.00259	CcSEcCtD
Spironolactone—Fluoxymesterone—ESR1—osteoporosis	0.000203	0.0822	CrCbGaD
Spironolactone—Pruritus—Etidronic acid—osteoporosis	0.000203	0.00258	CcSEcCtD
Spironolactone—Feeling abnormal—Alendronate—osteoporosis	0.000201	0.00256	CcSEcCtD
Spironolactone—Muscle spasms—Zoledronate—osteoporosis	0.0002	0.00255	CcSEcCtD
Spironolactone—Urticaria—Estropipate—osteoporosis	0.000197	0.0025	CcSEcCtD
Spironolactone—Diarrhoea—Etidronic acid—osteoporosis	0.000196	0.00249	CcSEcCtD
Spironolactone—Body temperature increased—Estropipate—osteoporosis	0.000196	0.00249	CcSEcCtD
Spironolactone—Feeling abnormal—Ibandronate—osteoporosis	0.000196	0.00249	CcSEcCtD
Spironolactone—Urticaria—Alendronate—osteoporosis	0.000194	0.00247	CcSEcCtD
Spironolactone—Ill-defined disorder—Zoledronate—osteoporosis	0.000193	0.00246	CcSEcCtD
Spironolactone—Body temperature increased—Alendronate—osteoporosis	0.000193	0.00245	CcSEcCtD
Spironolactone—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000193	0.00245	CcSEcCtD
Spironolactone—Discomfort—Pamidronate—osteoporosis	0.000192	0.00244	CcSEcCtD
Spironolactone—Body temperature increased—Raloxifene—osteoporosis	0.00019	0.00241	CcSEcCtD
Spironolactone—Urticaria—Ibandronate—osteoporosis	0.000189	0.0024	CcSEcCtD
Spironolactone—Malaise—Zoledronate—osteoporosis	0.000188	0.00239	CcSEcCtD
Spironolactone—Body temperature increased—Ibandronate—osteoporosis	0.000188	0.00239	CcSEcCtD
Spironolactone—Confusional state—Pamidronate—osteoporosis	0.000188	0.00239	CcSEcCtD
Spironolactone—Leukopenia—Zoledronate—osteoporosis	0.000186	0.00237	CcSEcCtD
Spironolactone—Anaphylactic shock—Pamidronate—osteoporosis	0.000186	0.00237	CcSEcCtD
Spironolactone—Urticaria—Calcitriol—osteoporosis	0.000185	0.00235	CcSEcCtD
Spironolactone—Body temperature increased—Calcitriol—osteoporosis	0.000184	0.00234	CcSEcCtD
Spironolactone—Hydrocortisone—SHBG—osteoporosis	0.000183	0.074	CrCbGaD
Spironolactone—Hypersensitivity—Estropipate—osteoporosis	0.000183	0.00232	CcSEcCtD
Spironolactone—Thrombocytopenia—Pamidronate—osteoporosis	0.000182	0.00232	CcSEcCtD
Spironolactone—Vomiting—Etidronic acid—osteoporosis	0.000182	0.00232	CcSEcCtD
Spironolactone—Rash—Etidronic acid—osteoporosis	0.000181	0.0023	CcSEcCtD
Spironolactone—Dermatitis—Etidronic acid—osteoporosis	0.00018	0.00229	CcSEcCtD
Spironolactone—Hypersensitivity—Alendronate—osteoporosis	0.00018	0.00229	CcSEcCtD
Spironolactone—Headache—Etidronic acid—osteoporosis	0.000179	0.00228	CcSEcCtD
Spironolactone—Methyltestosterone—CYP19A1—osteoporosis	0.000178	0.0721	CrCbGaD
Spironolactone—Pruritus—Estropipate—osteoporosis	0.000175	0.00223	CcSEcCtD
Spironolactone—Discomfort—Zoledronate—osteoporosis	0.000175	0.00223	CcSEcCtD
Spironolactone—Hypersensitivity—Ibandronate—osteoporosis	0.000175	0.00223	CcSEcCtD
Spironolactone—Medroxyprogesterone Acetate—ESR1—osteoporosis	0.000174	0.0705	CrCbGaD
Spironolactone—Erythema multiforme—Estradiol—osteoporosis	0.000174	0.00222	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000173	0.00221	CcSEcCtD
Spironolactone—Pruritus—Alendronate—osteoporosis	0.000173	0.0022	CcSEcCtD
Spironolactone—Confusional state—Zoledronate—osteoporosis	0.000171	0.00218	CcSEcCtD
Spironolactone—Hypersensitivity—Calcitriol—osteoporosis	0.000171	0.00218	CcSEcCtD
Spironolactone—Nausea—Etidronic acid—osteoporosis	0.00017	0.00216	CcSEcCtD
Spironolactone—Anaphylactic shock—Zoledronate—osteoporosis	0.00017	0.00216	CcSEcCtD
Spironolactone—Diarrhoea—Estropipate—osteoporosis	0.00017	0.00216	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Risedronate—osteoporosis	0.000169	0.00215	CcSEcCtD
Spironolactone—Pruritus—Ibandronate—osteoporosis	0.000168	0.00214	CcSEcCtD
Spironolactone—Diarrhoea—Alendronate—osteoporosis	0.000167	0.00212	CcSEcCtD
Spironolactone—Thrombocytopenia—Zoledronate—osteoporosis	0.000166	0.00212	CcSEcCtD
Spironolactone—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000165	0.0021	CcSEcCtD
Spironolactone—Somnolence—Pamidronate—osteoporosis	0.000165	0.0021	CcSEcCtD
Spironolactone—Pruritus—Calcitriol—osteoporosis	0.000165	0.00209	CcSEcCtD
Spironolactone—Diarrhoea—Raloxifene—osteoporosis	0.000164	0.00209	CcSEcCtD
Spironolactone—Dizziness—Estropipate—osteoporosis	0.000164	0.00208	CcSEcCtD
Spironolactone—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000164	0.00208	CcSEcCtD
Spironolactone—Alopecia—Estradiol—osteoporosis	0.000163	0.00207	CcSEcCtD
Spironolactone—Diarrhoea—Ibandronate—osteoporosis	0.000163	0.00207	CcSEcCtD
Spironolactone—Dizziness—Alendronate—osteoporosis	0.000161	0.00205	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000161	0.00204	CcSEcCtD
Spironolactone—Urticaria—Ethinyl Estradiol—osteoporosis	0.00016	0.00203	CcSEcCtD
Spironolactone—Diarrhoea—Calcitriol—osteoporosis	0.000159	0.00202	CcSEcCtD
Spironolactone—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000159	0.00202	CcSEcCtD
Spironolactone—Dizziness—Raloxifene—osteoporosis	0.000159	0.00202	CcSEcCtD
Spironolactone—Vomiting—Estropipate—osteoporosis	0.000158	0.002	CcSEcCtD
Spironolactone—Dizziness—Ibandronate—osteoporosis	0.000157	0.002	CcSEcCtD
Spironolactone—Rash—Estropipate—osteoporosis	0.000156	0.00199	CcSEcCtD
Spironolactone—Dermatitis—Estropipate—osteoporosis	0.000156	0.00199	CcSEcCtD
Spironolactone—Urticaria—Risedronate—osteoporosis	0.000156	0.00198	CcSEcCtD
Spironolactone—Headache—Estropipate—osteoporosis	0.000155	0.00197	CcSEcCtD
Spironolactone—Vomiting—Alendronate—osteoporosis	0.000155	0.00197	CcSEcCtD
Spironolactone—Body temperature increased—Risedronate—osteoporosis	0.000155	0.00197	CcSEcCtD
Spironolactone—Muscle spasms—Estradiol—osteoporosis	0.000154	0.00196	CcSEcCtD
Spironolactone—Rash—Alendronate—osteoporosis	0.000154	0.00196	CcSEcCtD
Spironolactone—Dermatitis—Alendronate—osteoporosis	0.000154	0.00196	CcSEcCtD
Spironolactone—Feeling abnormal—Pamidronate—osteoporosis	0.000153	0.00195	CcSEcCtD
Spironolactone—Headache—Alendronate—osteoporosis	0.000153	0.00194	CcSEcCtD
Spironolactone—Vomiting—Raloxifene—osteoporosis	0.000153	0.00194	CcSEcCtD
Spironolactone—Rash—Raloxifene—osteoporosis	0.000151	0.00192	CcSEcCtD
Spironolactone—Dermatitis—Raloxifene—osteoporosis	0.000151	0.00192	CcSEcCtD
Spironolactone—Somnolence—Zoledronate—osteoporosis	0.000151	0.00192	CcSEcCtD
Spironolactone—Vomiting—Ibandronate—osteoporosis	0.000151	0.00192	CcSEcCtD
Spironolactone—Headache—Raloxifene—osteoporosis	0.00015	0.00191	CcSEcCtD
Spironolactone—Rash—Ibandronate—osteoporosis	0.00015	0.00191	CcSEcCtD
Spironolactone—Dermatitis—Ibandronate—osteoporosis	0.00015	0.0019	CcSEcCtD
Spironolactone—Progesterone—SHBG—osteoporosis	0.000149	0.0603	CrCbGaD
Spironolactone—Ill-defined disorder—Estradiol—osteoporosis	0.000149	0.00189	CcSEcCtD
Spironolactone—Headache—Ibandronate—osteoporosis	0.000149	0.00189	CcSEcCtD
Spironolactone—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000148	0.00188	CcSEcCtD
Spironolactone—Vomiting—Calcitriol—osteoporosis	0.000148	0.00188	CcSEcCtD
Spironolactone—Nausea—Estropipate—osteoporosis	0.000147	0.00187	CcSEcCtD
Spironolactone—Body temperature increased—Pamidronate—osteoporosis	0.000147	0.00187	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000147	0.00187	CcSEcCtD
Spironolactone—Rash—Calcitriol—osteoporosis	0.000147	0.00187	CcSEcCtD
Spironolactone—Dermatitis—Calcitriol—osteoporosis	0.000147	0.00186	CcSEcCtD
Spironolactone—Headache—Calcitriol—osteoporosis	0.000146	0.00185	CcSEcCtD
Spironolactone—Somnolence—Conjugated Estrogens—osteoporosis	0.000146	0.00185	CcSEcCtD
Spironolactone—Nausea—Alendronate—osteoporosis	0.000145	0.00184	CcSEcCtD
Spironolactone—Malaise—Estradiol—osteoporosis	0.000145	0.00184	CcSEcCtD
Spironolactone—Hypersensitivity—Risedronate—osteoporosis	0.000144	0.00183	CcSEcCtD
Spironolactone—Nausea—Raloxifene—osteoporosis	0.000143	0.00181	CcSEcCtD
Spironolactone—Pruritus—Ethinyl Estradiol—osteoporosis	0.000142	0.00181	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000141	0.0018	CcSEcCtD
Spironolactone—Nausea—Ibandronate—osteoporosis	0.000141	0.00179	CcSEcCtD
Spironolactone—Testosterone—SHBG—osteoporosis	0.000141	0.057	CrCbGaD
Spironolactone—Feeling abnormal—Zoledronate—osteoporosis	0.00014	0.00178	CcSEcCtD
Spironolactone—Pruritus—Risedronate—osteoporosis	0.000139	0.00176	CcSEcCtD
Spironolactone—Nausea—Calcitriol—osteoporosis	0.000138	0.00176	CcSEcCtD
Spironolactone—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000137	0.00175	CcSEcCtD
Spironolactone—Hypersensitivity—Pamidronate—osteoporosis	0.000137	0.00174	CcSEcCtD
Spironolactone—Urticaria—Zoledronate—osteoporosis	0.000135	0.00172	CcSEcCtD
Spironolactone—Discomfort—Estradiol—osteoporosis	0.000135	0.00172	CcSEcCtD
Spironolactone—Body temperature increased—Zoledronate—osteoporosis	0.000134	0.00171	CcSEcCtD
Spironolactone—Diarrhoea—Risedronate—osteoporosis	0.000134	0.0017	CcSEcCtD
Spironolactone—Dizziness—Ethinyl Estradiol—osteoporosis	0.000133	0.00169	CcSEcCtD
Spironolactone—Confusional state—Estradiol—osteoporosis	0.000132	0.00168	CcSEcCtD
Spironolactone—Pruritus—Pamidronate—osteoporosis	0.000132	0.00167	CcSEcCtD
Spironolactone—Anaphylactic shock—Estradiol—osteoporosis	0.000131	0.00167	CcSEcCtD
Spironolactone—Urticaria—Conjugated Estrogens—osteoporosis	0.00013	0.00165	CcSEcCtD
Spironolactone—Dizziness—Risedronate—osteoporosis	0.000129	0.00165	CcSEcCtD
Spironolactone—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000129	0.00165	CcSEcCtD
Spironolactone—Vomiting—Ethinyl Estradiol—osteoporosis	0.000128	0.00162	CcSEcCtD
Spironolactone—Diarrhoea—Pamidronate—osteoporosis	0.000127	0.00162	CcSEcCtD
Spironolactone—Rash—Ethinyl Estradiol—osteoporosis	0.000127	0.00161	CcSEcCtD
Spironolactone—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000127	0.00161	CcSEcCtD
Spironolactone—Headache—Ethinyl Estradiol—osteoporosis	0.000126	0.0016	CcSEcCtD
Spironolactone—Hypersensitivity—Zoledronate—osteoporosis	0.000125	0.00159	CcSEcCtD
Spironolactone—Vomiting—Risedronate—osteoporosis	0.000124	0.00158	CcSEcCtD
Spironolactone—Rash—Risedronate—osteoporosis	0.000123	0.00157	CcSEcCtD
Spironolactone—Dermatitis—Risedronate—osteoporosis	0.000123	0.00157	CcSEcCtD
Spironolactone—Dizziness—Pamidronate—osteoporosis	0.000123	0.00157	CcSEcCtD
Spironolactone—Headache—Risedronate—osteoporosis	0.000123	0.00156	CcSEcCtD
Spironolactone—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000121	0.00153	CcSEcCtD
Spironolactone—Pruritus—Zoledronate—osteoporosis	0.00012	0.00153	CcSEcCtD
Spironolactone—Nausea—Ethinyl Estradiol—osteoporosis	0.000119	0.00152	CcSEcCtD
Spironolactone—Vomiting—Pamidronate—osteoporosis	0.000118	0.00151	CcSEcCtD
Spironolactone—Rash—Pamidronate—osteoporosis	0.000117	0.00149	CcSEcCtD
Spironolactone—Dermatitis—Pamidronate—osteoporosis	0.000117	0.00149	CcSEcCtD
Spironolactone—Headache—Pamidronate—osteoporosis	0.000117	0.00148	CcSEcCtD
Spironolactone—Somnolence—Estradiol—osteoporosis	0.000116	0.00148	CcSEcCtD
Spironolactone—Diarrhoea—Zoledronate—osteoporosis	0.000116	0.00148	CcSEcCtD
Spironolactone—Nausea—Risedronate—osteoporosis	0.000116	0.00148	CcSEcCtD
Spironolactone—Pruritus—Conjugated Estrogens—osteoporosis	0.000116	0.00147	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Estradiol—osteoporosis	0.000113	0.00144	CcSEcCtD
Spironolactone—Dizziness—Zoledronate—osteoporosis	0.000112	0.00143	CcSEcCtD
Spironolactone—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000112	0.00142	CcSEcCtD
Spironolactone—Nausea—Pamidronate—osteoporosis	0.000111	0.00141	CcSEcCtD
Spironolactone—Dizziness—Conjugated Estrogens—osteoporosis	0.000108	0.00138	CcSEcCtD
Spironolactone—Vomiting—Zoledronate—osteoporosis	0.000108	0.00137	CcSEcCtD
Spironolactone—Feeling abnormal—Estradiol—osteoporosis	0.000108	0.00137	CcSEcCtD
Spironolactone—Rash—Zoledronate—osteoporosis	0.000107	0.00136	CcSEcCtD
Spironolactone—Dermatitis—Zoledronate—osteoporosis	0.000107	0.00136	CcSEcCtD
Spironolactone—Headache—Zoledronate—osteoporosis	0.000107	0.00135	CcSEcCtD
Spironolactone—Vomiting—Conjugated Estrogens—osteoporosis	0.000104	0.00132	CcSEcCtD
Spironolactone—Urticaria—Estradiol—osteoporosis	0.000104	0.00132	CcSEcCtD
Spironolactone—Body temperature increased—Estradiol—osteoporosis	0.000104	0.00132	CcSEcCtD
Spironolactone—Testosterone—CYP19A1—osteoporosis	0.000104	0.0418	CrCbGaD
Spironolactone—Rash—Conjugated Estrogens—osteoporosis	0.000103	0.00131	CcSEcCtD
Spironolactone—Dermatitis—Conjugated Estrogens—osteoporosis	0.000103	0.00131	CcSEcCtD
Spironolactone—Headache—Conjugated Estrogens—osteoporosis	0.000103	0.0013	CcSEcCtD
Spironolactone—Nausea—Zoledronate—osteoporosis	0.000101	0.00128	CcSEcCtD
Spironolactone—Progesterone—ESR1—osteoporosis	0.000101	0.0407	CrCbGaD
Spironolactone—Nausea—Conjugated Estrogens—osteoporosis	9.72e-05	0.00124	CcSEcCtD
Spironolactone—Hypersensitivity—Estradiol—osteoporosis	9.65e-05	0.00123	CcSEcCtD
Spironolactone—Pruritus—Estradiol—osteoporosis	9.27e-05	0.00118	CcSEcCtD
Spironolactone—Diarrhoea—Estradiol—osteoporosis	8.96e-05	0.00114	CcSEcCtD
Spironolactone—Dizziness—Estradiol—osteoporosis	8.66e-05	0.0011	CcSEcCtD
Spironolactone—Vomiting—Estradiol—osteoporosis	8.33e-05	0.00106	CcSEcCtD
Spironolactone—Rash—Estradiol—osteoporosis	8.26e-05	0.00105	CcSEcCtD
Spironolactone—Dermatitis—Estradiol—osteoporosis	8.25e-05	0.00105	CcSEcCtD
Spironolactone—Headache—Estradiol—osteoporosis	8.21e-05	0.00104	CcSEcCtD
Spironolactone—Nausea—Estradiol—osteoporosis	7.78e-05	0.00099	CcSEcCtD
Spironolactone—PGR—Generic Transcription Pathway—ESR2—osteoporosis	4.64e-05	0.000953	CbGpPWpGaD
Spironolactone—NR3C2—Generic Transcription Pathway—ESR1—osteoporosis	4.62e-05	0.000949	CbGpPWpGaD
Spironolactone—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	4.59e-05	0.000942	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—osteoporosis	4.51e-05	0.000925	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—osteoporosis	4.46e-05	0.000916	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CA2—osteoporosis	4.46e-05	0.000916	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—OXCT1—osteoporosis	4.46e-05	0.000916	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—IL6R—osteoporosis	4.46e-05	0.000915	CbGpPWpGaD
Spironolactone—AR—Gene Expression—U2AF1—osteoporosis	4.44e-05	0.000912	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SOST—osteoporosis	4.37e-05	0.000898	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—MGLL—osteoporosis	4.35e-05	0.000892	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—RPL24—osteoporosis	4.33e-05	0.00089	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	4.32e-05	0.000887	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoporosis	4.31e-05	0.000886	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—IDH2—osteoporosis	4.29e-05	0.000881	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	4.19e-05	0.000859	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—IRS1—osteoporosis	4.16e-05	0.000855	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.16e-05	0.000854	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—PSMA2—osteoporosis	4.11e-05	0.000843	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—PSMA5—osteoporosis	4.11e-05	0.000843	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.1e-05	0.000842	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	4.08e-05	0.000837	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CYP27A1—osteoporosis	4.03e-05	0.000828	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	3.97e-05	0.000815	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PTH1R—osteoporosis	3.96e-05	0.000812	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CALCR—osteoporosis	3.96e-05	0.000812	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—ACP5—osteoporosis	3.92e-05	0.000805	CbGpPWpGaD
Spironolactone—NR3C1—Endoderm Differentiation—TGFB1—osteoporosis	3.88e-05	0.000797	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.87e-05	0.000795	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—IGF1—osteoporosis	3.86e-05	0.000792	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—MYC—osteoporosis	3.8e-05	0.000781	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—TGFB1—osteoporosis	3.79e-05	0.000779	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—FDPS—osteoporosis	3.79e-05	0.000779	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PKM—osteoporosis	3.79e-05	0.000779	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	3.74e-05	0.000767	CbGpPWpGaD
Spironolactone—CYP2C8—Phase 1 - Functionalization of compounds—POMC—osteoporosis	3.72e-05	0.000764	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—IDH2—osteoporosis	3.7e-05	0.000759	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—VDR—osteoporosis	3.68e-05	0.000756	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—ESR2—osteoporosis	3.67e-05	0.000753	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—TPI1—osteoporosis	3.65e-05	0.000749	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GPD2—osteoporosis	3.6e-05	0.000738	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PGLS—osteoporosis	3.6e-05	0.000738	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—ESR2—osteoporosis	3.54e-05	0.000726	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CYP27A1—osteoporosis	3.48e-05	0.000713	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—P4HB—osteoporosis	3.43e-05	0.000704	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—IL1B—osteoporosis	3.39e-05	0.000696	CbGpPWpGaD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—osteoporosis	3.38e-05	0.000695	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—IL6R—osteoporosis	3.38e-05	0.000694	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—ACP5—osteoporosis	3.38e-05	0.000694	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—U2AF1—osteoporosis	3.37e-05	0.000692	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—GAPDH—osteoporosis	3.37e-05	0.000691	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.34e-05	0.000685	CbGpPWpGaD
Spironolactone—AR—Gene Expression—RPL24—osteoporosis	3.3e-05	0.000678	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ATIC—osteoporosis	3.29e-05	0.000675	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PNP—osteoporosis	3.29e-05	0.000675	CbGpPWpGaD
Spironolactone—CYP2C8—Biological oxidations—CYP19A1—osteoporosis	3.29e-05	0.000675	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—RAP1A—osteoporosis	3.28e-05	0.000673	CbGpPWpGaD
Spironolactone—CYP2C8—Metapathway biotransformation—CYP19A1—osteoporosis	3.24e-05	0.000666	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—TPI1—osteoporosis	3.14e-05	0.000645	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MGLL—osteoporosis	3.14e-05	0.000645	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	3.09e-05	0.000634	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—LRP5—osteoporosis	3.07e-05	0.00063	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	3.01e-05	0.000617	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—P4HB—osteoporosis	2.96e-05	0.000607	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—LRP6—osteoporosis	2.93e-05	0.000602	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—VDR—osteoporosis	2.91e-05	0.000598	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	2.9e-05	0.000596	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—GAPDH—osteoporosis	2.9e-05	0.000595	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—IL6—osteoporosis	2.86e-05	0.000587	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.86e-05	0.000587	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—RAP1A—osteoporosis	2.83e-05	0.00058	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—ESR1—osteoporosis	2.82e-05	0.000578	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—VDR—osteoporosis	2.81e-05	0.000576	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CA2—osteoporosis	2.8e-05	0.000574	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—OXCT1—osteoporosis	2.8e-05	0.000574	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—MGLL—osteoporosis	2.73e-05	0.00056	CbGpPWpGaD
Spironolactone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	2.72e-05	0.000558	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—MYC—osteoporosis	2.71e-05	0.000556	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—ESR2—osteoporosis	2.68e-05	0.000551	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—IL6—osteoporosis	2.66e-05	0.000546	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—ENO1—osteoporosis	2.65e-05	0.000544	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PSMA2—osteoporosis	2.61e-05	0.000536	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PSMA5—osteoporosis	2.61e-05	0.000536	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—IL1B—osteoporosis	2.57e-05	0.000528	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.57e-05	0.000528	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—IL6—osteoporosis	2.52e-05	0.000517	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—RPL24—osteoporosis	2.51e-05	0.000514	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—PSMA2—osteoporosis	2.5e-05	0.000514	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—PSMA5—osteoporosis	2.5e-05	0.000514	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TLN1—osteoporosis	2.48e-05	0.000509	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.46e-05	0.000506	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—TNF—osteoporosis	2.46e-05	0.000505	CbGpPWpGaD
Spironolactone—ABCC2—NRF2 pathway—TGFB1—osteoporosis	2.41e-05	0.000494	CbGpPWpGaD
Spironolactone—NR3C2—Generic Transcription Pathway—MYC—osteoporosis	2.4e-05	0.000494	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	2.4e-05	0.000494	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—IL1B—osteoporosis	2.38e-05	0.000489	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—IDH2—osteoporosis	2.32e-05	0.000476	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—TGFB1—osteoporosis	2.31e-05	0.000475	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—ENO1—osteoporosis	2.28e-05	0.000469	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	2.28e-05	0.000468	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PSMA5—osteoporosis	2.25e-05	0.000462	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PSMA2—osteoporosis	2.25e-05	0.000462	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	2.25e-05	0.000461	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	2.24e-05	0.00046	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—ESR2—osteoporosis	2.24e-05	0.000459	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—ESR1—osteoporosis	2.23e-05	0.000457	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CYP27A1—osteoporosis	2.18e-05	0.000447	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—TNF—osteoporosis	2.16e-05	0.000443	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—ESR1—osteoporosis	2.15e-05	0.00044	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—P4HB—osteoporosis	2.14e-05	0.000438	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—VDR—osteoporosis	2.13e-05	0.000437	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ACP5—osteoporosis	2.12e-05	0.000435	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CYP19A1—osteoporosis	2.12e-05	0.000435	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.09e-05	0.00043	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	2.09e-05	0.00043	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PTH—osteoporosis	2.08e-05	0.000427	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.04e-05	0.00042	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—RAP1A—osteoporosis	2.04e-05	0.000419	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CNR2—osteoporosis	2.02e-05	0.000416	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—ADCY5—osteoporosis	2e-05	0.00041	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NFATC1—osteoporosis	1.99e-05	0.000409	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—IL6—osteoporosis	1.99e-05	0.000408	CbGpPWpGaD
Spironolactone—CYP2C8—Biological oxidations—POMC—osteoporosis	1.98e-05	0.000406	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—DKK1—osteoporosis	1.98e-05	0.000406	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—TPI1—osteoporosis	1.97e-05	0.000405	CbGpPWpGaD
Spironolactone—AR—Gene Expression—PSMA5—osteoporosis	1.91e-05	0.000391	CbGpPWpGaD
Spironolactone—AR—Gene Expression—PSMA2—osteoporosis	1.91e-05	0.000391	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—WNT1—osteoporosis	1.9e-05	0.000391	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—TNF—osteoporosis	1.87e-05	0.000383	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—FDPS—osteoporosis	1.86e-05	0.000383	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PKM—osteoporosis	1.86e-05	0.000383	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—P4HB—osteoporosis	1.85e-05	0.00038	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—FGA—osteoporosis	1.85e-05	0.00038	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—TGFB1—osteoporosis	1.85e-05	0.00038	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CYP19A1—osteoporosis	1.83e-05	0.000375	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GAPDH—osteoporosis	1.82e-05	0.000373	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.82e-05	0.000373	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—VDR—osteoporosis	1.77e-05	0.000364	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—RAP1A—osteoporosis	1.77e-05	0.000364	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PGLS—osteoporosis	1.77e-05	0.000363	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GPD2—osteoporosis	1.77e-05	0.000363	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	1.76e-05	0.000361	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—IL6—osteoporosis	1.74e-05	0.000358	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—ADCY5—osteoporosis	1.73e-05	0.000355	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—TNF—osteoporosis	1.73e-05	0.000355	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—GPX1—osteoporosis	1.73e-05	0.000354	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PTHLH—osteoporosis	1.72e-05	0.000353	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—BMP2—osteoporosis	1.72e-05	0.000353	CbGpPWpGaD
Spironolactone—AR—Gene Expression—ESR2—osteoporosis	1.7e-05	0.00035	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—FGB—osteoporosis	1.68e-05	0.000346	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—ESR1—osteoporosis	1.63e-05	0.000334	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PSMA2—osteoporosis	1.63e-05	0.000334	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PSMA5—osteoporosis	1.63e-05	0.000334	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—FDPS—osteoporosis	1.62e-05	0.000333	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PKM—osteoporosis	1.62e-05	0.000333	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ATIC—osteoporosis	1.62e-05	0.000332	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PNP—osteoporosis	1.62e-05	0.000332	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—MTHFR—osteoporosis	1.59e-05	0.000327	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.54e-05	0.000317	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GPD2—osteoporosis	1.54e-05	0.000316	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PGLS—osteoporosis	1.54e-05	0.000316	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	1.52e-05	0.000313	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CALCA—osteoporosis	1.52e-05	0.000311	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—IL6—osteoporosis	1.51e-05	0.000309	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—ADCY5—osteoporosis	1.49e-05	0.000306	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—GPX1—osteoporosis	1.49e-05	0.000305	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—MYC—osteoporosis	1.46e-05	0.000301	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—PSMA2—osteoporosis	1.45e-05	0.000297	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—PSMA5—osteoporosis	1.45e-05	0.000297	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ENO1—osteoporosis	1.43e-05	0.000294	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PSMA2—osteoporosis	1.41e-05	0.00029	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PSMA5—osteoporosis	1.41e-05	0.00029	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PNP—osteoporosis	1.41e-05	0.000289	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ATIC—osteoporosis	1.41e-05	0.000289	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—KL—osteoporosis	1.38e-05	0.000283	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CA2—osteoporosis	1.37e-05	0.000282	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—OXCT1—osteoporosis	1.37e-05	0.000282	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—MTHFR—osteoporosis	1.37e-05	0.000282	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—ESR1—osteoporosis	1.36e-05	0.000278	CbGpPWpGaD
Spironolactone—AR—Gene Expression—VDR—osteoporosis	1.35e-05	0.000277	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—MGLL—osteoporosis	1.34e-05	0.000275	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—ESR2—osteoporosis	1.29e-05	0.000265	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—POMC—osteoporosis	1.27e-05	0.000261	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.26e-05	0.000259	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—OXCT1—osteoporosis	1.2e-05	0.000246	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CA2—osteoporosis	1.2e-05	0.000246	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—MGLL—osteoporosis	1.17e-05	0.00024	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—MYC—osteoporosis	1.16e-05	0.000238	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CYP19A1—osteoporosis	1.14e-05	0.000235	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—IDH2—osteoporosis	1.14e-05	0.000234	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—MYC—osteoporosis	1.12e-05	0.000229	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—POMC—osteoporosis	1.1e-05	0.000225	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ADCY5—osteoporosis	1.08e-05	0.000221	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP27A1—osteoporosis	1.07e-05	0.00022	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SPP1—osteoporosis	1.04e-05	0.000214	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ACP5—osteoporosis	1.04e-05	0.000214	CbGpPWpGaD
Spironolactone—AR—Gene Expression—ESR1—osteoporosis	1.03e-05	0.000212	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.03e-05	0.000211	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—VDR—osteoporosis	1.03e-05	0.000211	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—IDH2—osteoporosis	9.92e-06	0.000204	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—TPI1—osteoporosis	9.68e-06	0.000199	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IRS2—osteoporosis	9.43e-06	0.000194	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ADCY5—osteoporosis	9.35e-06	0.000192	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP27A1—osteoporosis	9.33e-06	0.000192	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GPX1—osteoporosis	9.32e-06	0.000191	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—LEP—osteoporosis	9.23e-06	0.00019	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	9.16e-06	0.000188	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	9.13e-06	0.000187	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—P4HB—osteoporosis	9.11e-06	0.000187	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ACP5—osteoporosis	9.08e-06	0.000186	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GAPDH—osteoporosis	8.94e-06	0.000183	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ESR1—osteoporosis	8.81e-06	0.000181	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—RAP1A—osteoporosis	8.7e-06	0.000179	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—MTHFR—osteoporosis	8.6e-06	0.000177	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	8.55e-06	0.000176	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	8.53e-06	0.000175	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—MYC—osteoporosis	8.47e-06	0.000174	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—TPI1—osteoporosis	8.44e-06	0.000173	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IRS1—osteoporosis	8.24e-06	0.000169	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—P4HB—osteoporosis	7.93e-06	0.000163	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—POMC—osteoporosis	7.93e-06	0.000163	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—ESR1—osteoporosis	7.84e-06	0.000161	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GAPDH—osteoporosis	7.79e-06	0.00016	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IL6R—osteoporosis	7.74e-06	0.000159	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IGF1—osteoporosis	7.63e-06	0.000157	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	7.59e-06	0.000156	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—RAP1A—osteoporosis	7.58e-06	0.000156	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—MYC—osteoporosis	7.05e-06	0.000145	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ENO1—osteoporosis	7.04e-06	0.000144	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PSMA2—osteoporosis	6.93e-06	0.000142	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PSMA5—osteoporosis	6.93e-06	0.000142	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—POMC—osteoporosis	6.88e-06	0.000141	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ENO1—osteoporosis	6.13e-06	0.000126	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PSMA2—osteoporosis	6.04e-06	0.000124	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PSMA5—osteoporosis	6.04e-06	0.000124	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP19A1—osteoporosis	5.63e-06	0.000115	CbGpPWpGaD
Spironolactone—AR—Gene Expression—MYC—osteoporosis	5.37e-06	0.00011	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP19A1—osteoporosis	4.9e-06	0.000101	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ADCY5—osteoporosis	4.6e-06	9.44e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MYC—osteoporosis	4.58e-06	9.41e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GPX1—osteoporosis	4.58e-06	9.4e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TGFB1—osteoporosis	4.57e-06	9.39e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—MTHFR—osteoporosis	4.23e-06	8.68e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—MYC—osteoporosis	4.08e-06	8.37e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ADCY5—osteoporosis	4e-06	8.22e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GPX1—osteoporosis	3.99e-06	8.19e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—MTHFR—osteoporosis	3.68e-06	7.56e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IL6—osteoporosis	3.45e-06	7.07e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—POMC—osteoporosis	3.38e-06	6.94e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—POMC—osteoporosis	2.95e-06	6.05e-05	CbGpPWpGaD
